ChemicalBook >> CAS DataBase List >>cefaloglycin

cefaloglycin

CAS No.
3577-01-3
Chemical Name:
cefaloglycin
Synonyms
Kafocin;Kefglycin;Lilly-39435;cefaloglycin;Cephaloglycin;Cefaloglycine;Cephaloglycin(anhydrous);FUBBGQLTSCSAON-PBFPGSCMSA-N;(6R,7R)-7-[(R)-2-Amino-2-phenylacetylamino]-3-(acetoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CBNumber:
CB8926010
Molecular Formula:
C18H19N3O6S
Molecular Weight:
405.42
MDL Number:
MFCD00056878
MOL File:
3577-01-3.mol
MSDS File:
SDS
Last updated:2023-05-09 09:30:54

cefaloglycin Properties

Melting point 236.5°C (rough estimate)
Boiling point 217.4°C (rough estimate)
Density 1.3328 (rough estimate)
refractive index 1.6390 (estimate)
storage temp. 2-8°C
solubility Aqueous Acid (Slightly), Methanol (Slightly, Heated)
form Solid
pka pKa 1.71(H2O t=25±2 I=0.1 ) (Uncertain);7.29(H2O t=25±2 I=0.1 ) (Uncertain)
color White to Pale Brown
Water Solubility 10.5g/L(25 ºC)
Stability Hygroscopic, Moisture Sensitive, Temperature Sensitive
FDA UNII HD2D469W6U

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS08
Signal word  Danger
Hazard statements  H334-H317
Precautionary statements  P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P261-P285-P304+P341-P342+P311-P501
Hazard Codes  Xn
Risk Statements  42/43
Safety Statements  36

cefaloglycin price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
TRC C258000 Cephaloglycin 3577-01-3 50mg $175 2021-12-16 Buy
American Custom Chemicals Corporation API0001931 CEPHALOGLYCIN 95.00% 3577-01-3 500MG $1358.28 2021-12-16 Buy
Product number Packaging Price Buy
C258000 50mg $175 Buy
API0001931 500MG $1358.28 Buy

cefaloglycin Chemical Properties,Uses,Production

Originator

Kefglycin,Shionogi,Japan,1969

Uses

Antibacterial.

Uses

Cefaloglycin is a first-generation cephalosporin antibiotic.

Definition

ChEBI: A cephalosporin antibiotic containing at the 7beta-position of the cephem skeleton an (R)-amino(phenyl)acetamido group.

Manufacturing Process

dl-Phenylglycine is resolved in a conventional manner by reaction with cinchonine, fractional crystallization of the resulting diastereoisomers, and acidification to release the phenylglycine enantiomorphs. D-phenylglycine, thus prepared, is reacted with carbobenzoxy chloride in a conventional manner to produce N-carbobenzoxy-D-phenylglycine.
A 0.60 g portion of N-carbobenzoxy-D-phenylglycine is dissolved in 10 ml of dry tetrahydrofuran. The solution is cooled in an ice-salt bath, and to it is added 0.29 ml of triethylamine with stirring over a period of 10 minutes, followed by 0.29 ml of isobutyl chloroformate, after which stirring is continued for 10 minutes at -5°C. During this time, 0.57 g of 7-aminocephalosporanic acid and 0.29 ml of triethylamine are dissolved in 5 ml of tetrahydrofuran and 5 ml of water, and the solution is centrifuged to remove a dark sludge. The clarified solution is cooled in ice and slowly added to the reaction mixture, and stirring is continued in the ice bath for 0.5 hour, followed by one hour at room temperature.
The reaction product mixture is a homogenous solution having a pH of about 6. It is evaporated under vacuum to a semisolid residue. To the residue are added 35 ml of water and a few drops of triethylamine to raise the pH to 8. The aqueous solution obtained thereby is extracted successively with 50 ml and 35 ml portions of ethyl acetate, the pH being adjusted to 2 at each extraction with hydrochloric acid. The extracts are combined, filtered, dried over sodium sulfate, stripped of solvent, and evaporated under vacuum. The product is 7-(N-carbobenzoxy-D-α-aminophenylacetamido)cephalosporanic acid in the form of a yellow-white amorphous solid weighing 1.10 g.
Of this material 1.0 g is dissolved in 150 ml of warm 95% ethyl alcohol. To the solution is added 1.0 g of 5% palladium on carbon catalyst, and the mixture is hydrogenated at room temperature and atmospheric pressure by bubbling hydrogen into it for 3 hours with stirring. The hydrogenation product is filtered. The solid phase, comprising the catalyst and the desired product, is suspended in ethyl acetate and water and adjusted to pH 2 with hydrochloric acid. The suspension is filtered to remove the catalyst. The aqueous phase is separated from the filtrate, and is evaporated under vacuum to recover the desired product, 7-(D-α-aminophenylacetamido)cephalosporanicacid.

brand name

Kafocin (Lilly).

Therapeutic Function

Antibacterial

cefaloglycin Preparation Products And Raw materials

cefaloglycin Suppliers

Global( 17)Suppliers
Supplier Tel Email Country ProdList Advantage
Shaanxi Dideu Medichem Co. Ltd
+86-029-89586680 +86-18192503167 1026@dideu.com China 9126 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 27945 58
BOC Sciences
16314854226; +16314854226 inquiry@bocsci.com United States 19743 58
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207 sales@molcore.com China 49739 58
Beijing HuaMeiHuLiBiological Chemical 010-56205725 waley188@sohu.com China 12338 58
Shanghai Han-Xiang Chemical Co., Ltd. 15971444841 amber@biochempartner.com China 3063 58
Hangzhou changru chemical co., ltd 18453016280 534091519@qq.com China 101 58
Energy Chemical 021-58432009 400-005-6266 marketing@energy-chemical.com China 44941 58
Changzhou Furuisi Biotechnology Co., Ltd 0519-85524369 3477467573@qq.com China 8618 58
Zhejiang Huida Biotech Co., LTD 0571-0571-89903882 15990081639 sunshixuan@huidabiotech.com China 3705 58

View Lastest Price from cefaloglycin manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
cefaloglycin USP/EP/BP pictures 2021-07-01 cefaloglycin USP/EP/BP
3577-01-3
US $1.10 / g 1g 99.9% 100 Tons Min Dideu Industries Group Limited

3577-01-3(cefaloglycin )Related Search:

Cephaloglycin(anhydrous) Kafocin Kefglycin Lilly-39435 (6R,7R)-3-(acetoxymethyl)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-8-keto-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-azanyl-2-phenyl-ethanoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Cefaloglycine cefaloglycin Cephaloglycin (6R,7R)-7-[(R)-2-Amino-2-phenylacetylamino]-3-(acetoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid FUBBGQLTSCSAON-PBFPGSCMSA-N 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-, (6R,7R)- 3577-01-3 357-71-3